Onderzoeker
Maxime Vanmechelen
- Disciplines:Kankerbiologie, Kankerdiagnose, Kankertherapie
Affiliaties
- Translationeel Cel- en Weefselonderzoek (Afdeling)
Lid
Vanaf1 okt 2020 → Heden
Projecten
1 - 1 of 1
- Proof of concept: immuuntherapie bij glioblastoma multiforme.Vanaf21 sep 2020 → HedenFinanciering: FWO mandaten
Publicaties
1 - 7 van 7
- Single-cell profiling and zebrafish avatars reveal LGALS1 as immunomodulating target in glioblastoma(2023)
Auteurs: Lise Finotto, Basiel Cole, Maxime Vanmechelen, Bram Boeckx, Diether Lambrechts, Ludo Van Den Bosch, Steven De Vleeschouwer, Frederik De Smet
- Cellular and molecular features related to exceptional therapy response and extreme long-term survival in glioblastoma(2023)
Auteurs: Maxime Vanmechelen, Paul Clement, Jean-françois Daisne, Isabelle Vanden Bempt, Raf Sciot, Abhishek Garg, Patrizia Agostinis, Frederik De Smet, Steven De Vleeschouwer
Pagina's: 11107 - 11126 - Patient-derived glioblastoma organoids reflect tumor heterogeneity and treatment sensitivity(2023)
Auteurs: Maxime Vanmechelen, Kim Kampen, Frederik De Smet
- SPATIAL MAPPING OF THERAPY-INDUCED, PATHOLOGICAL CHANGES IN GLIOBLASTOMA AT SINGLE-CELL RESOLUTION(2021)
Auteurs: Maxime Vanmechelen, Sien Bevers, Julie Messiaen, Yannick Van Herck, Francesca Bosisio, Steven De Vleeschouwer, Paul Clement, Raf Sciot, Frederik De Smet
Pagina's: 119 - 119 - Validation of the Correlation Between Single Nucleotide Polymorphism rs307826 in VEGFR3 and Outcome in Metastatic Clear-Cell Renal Cell Carcinoma Patients Treated with Sunitinib(2020)
Auteurs: Benoit Beuselinck, Annelies Verbiest, Maxime Vanmechelen, Eduard Roussel, Maarten Albersen, Marcella Baldewijns, Diether Lambrechts
- Fibroblast Growth Factor Receptor-2 Polymorphism rs2981582 is Correlated With Progression-free Survival and Overall Survival in Patients With Metastatic Clear-cell Renal Cell Carcinoma Treated With Sunitinib(2019)
Auteurs: Maxime Vanmechelen, Diether Lambrechts, Annelies Verbiest, Patrick Schöffski, Herlinde Dumez, Evelyne Lerut, Maarten Albersen, Benoit Beuselinck
Pagina's: E235 - E246 - Point-of-care heart-type fatty acid binding protein versus high-sensitivity troponin T testing in emergency patients at high risk for acute coronary syndrome(2016)
Auteurs: Maxime Vanmechelen
Pagina's: 177 - 184